RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 132 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $298,000 | +26.8% | 113,800 | +24.4% | 0.00% | 0.0% |
| Q1 2019 | $235,000 | +11.9% | 91,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $210,000 | -45.3% | 91,500 | -23.5% | 0.00% | 0.0% |
| Q3 2018 | $384,000 | +13.6% | 119,600 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $338,000 | +160.0% | 119,600 | +258.1% | 0.00% | 0.0% |
| Q4 2017 | $130,000 | +14.0% | 33,400 | -25.6% | 0.00% | – |
| Q3 2017 | $114,000 | -6.6% | 44,900 | +0.2% | 0.00% | -100.0% |
| Q2 2017 | $122,000 | -97.9% | 44,800 | -97.7% | 0.00% | -96.2% |
| Q4 2015 | $5,862,000 | +20.1% | 1,934,806 | -2.1% | 0.03% | +30.0% |
| Q3 2015 | $4,879,000 | +14.7% | 1,975,475 | +49.1% | 0.02% | +17.6% |
| Q2 2015 | $4,252,000 | – | 1,324,709 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |